GSK3B and adrenoleukodystrophy: For this, we assessed whether specific GSK‐3β inhibitors (CT99021 and SB216763; Coghlan et al, 2000; Ring et al, 2003) could restore a normal NRF2‐dependent response in X‐ALD fibroblasts.